Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Peripheral Neuropathy Market’s Growth Trajectory From 2025 To 2034?
The market size for peripheral neuropathy has experienced swift growth in the recent past. It is projected to escalate from $4.09 billion in 2024 to $4.59 billion in 2025, boasting a compound annual growth rate (CAGR) of 12.2%. Factors such as the increasing incidence of chronic conditions like diabetes, growing consciousness about neuropathic pain handling, a burgeoning global aging population, the development of the healthcare infrastructure, access to dedicated treatment centres, government measures for enhanced neurological healthcare services, and the rising acceptance of innovative treatment alternatives have contributed to the growth during the historical period.
Expectations state that the market size for peripheral neuropathy is poised for a significant growth spurt in the following years, hitting an estimated $7.24 billion by 2029 at a compound annual growth rate (CAGR) of 12.1%. The predicted increase during this forecast period can be linked to escalating chronic illnesses rates, with a specific focus on diabetes and cancer, progressing pharmacological therapies focused on neuropathic pain routes, heightened investment towards creating innovative treatment techniques, as well as the inclusion of digital health alternatives for remote, personalized neuropathic symptom management. It also considers the growing emphasis on patient-focused care models and improved availability of multidisciplinary healthcare services. The forecast period is also marked by notable trends such as an uptick in the adoption of customized treatment, increasing usage of wearable technology for real-time tracking of neuropathic symptoms and treatment processes, wider reach of telemedicine services for distant consultations and follow-ups, creation of targeted therapies addressing distinct neuropathic pain routes and mechanisms, breakthroughs in regenerative medicine methods and the integration of cognitive behavioral therapy and mindfulness-informed interventions through digital therapeutic platforms. Technological progress in tools for early diagnosis and monitoring of peripheral neuropathy is also a significant contributing factor.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16507&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Peripheral Neuropathy Market?
The surge in diabetes cases is anticipated to drive the expansion of the peripheral neuropathy market. Diabetes is a chronic disease defined by excessive glucose levels in the blood, a result of the body’s inability to produce or utilize insulin effectively. The surge in diabetes cases can be largely attributed to rising obesity rates, inactive lifestyles, and an aging demographic. Diabetes has the potential to lead to peripheral neuropathy by harming nerves due to extended periods of elevated blood sugar, causing symptoms such as pain, tingling, and numbness in the extremities. It is vital to manage blood sugar levels effectively to prevent or slow down this complication’s progress. For example, a report by The British Diabetic Association, a diabetes charity based in the UK, revealed in April 2023 that 4.3 million individuals in the UK have been diagnosed with diabetes. Registration data for 2021-22 shows a rise of 148,951 cases compared to 2020-21. Moreover, over 2.4 million individuals in the UK are at a high risk of developing type 2 diabetes. Hence, the increasing occurrence of diabetes is spurring the growth of the peripheral neuropathy market.
Which Key Market Segments Comprise the Peripheral Neuropathy Market and Drive Its Revenue Growth?
The peripheral neuropathymarket covered in this report is segmented –
1) By Type: Chemotherapy-Induced; Diabetic; Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated; Idiopathic
2) By Diagnosis: Blood Test; Biopsy; Imaging; Other Diagnosis
3) By Treatment: Medications; Antidepressants; Anti-Seizure Medication; Pain Reliever; Topical Treatment; Therapies; Nerve Stimulation; Plasma Exchange; Physical Therapy; Other Treatments
4) By End-User: Hospitals; Clinics; Ambulatory Centers
Subsegments:
1) By Chemotherapy-Induced: Taxane-Induced Peripheral Neuropathy; Platinum-Based Drug-Induced Neuropathy; Other Chemotherapy-Induced Neuropathies
2) By Diabetic: Type 1 Diabetes-Induced Peripheral Neuropathy; Type 2 Diabetes-Induced Peripheral Neuropathy
3) By Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS) Associated: HIV-Associated Peripheral Neuropathy; AIDS-Related Peripheral Neuropathy
4) By Idiopathic: Acute Idiopathic Neuropathy; Chronic Idiopathic Neuropathy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16507&type=smp
Which Areas Are Leading Regions in the Peripheral Neuropathy Market Expansion Across the Globe?
North America was the largest region in the peripheral neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in thePeripheral Neuropathy Market Over the Coming Years?
Leading enterprises in the peripheral neuropathy market are concentrating on innovating advanced solutions like point-of-care devices to enhance the diagnosis and treatment of the disease. Tools like point-of-care quantitative screening tests for peripheral neuropathy are being used to quickly identify nerve damage, specifically in people with diabetes. In this context, NeuroMetrix Inc, a producer of non-invasive medical apparatus from the US, launched the DPNCheck 2.0 point-of-care device for identifying peripheral neuropathy in January 2023. The device uses nerve conduction technology to identify systemic peripheral nerve deterioration that could lead to severe diseases like diabetic peripheral neuropathy (DPN). The tool facilitates quick patient screening, employing quantitative measurements of peripheral nerve function, establishing its efficiency and accuracy over traditional methods such as monofilament and tuning fork tests.
View the full report here:
https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report
How Is the Peripheral Neuropathy Market Conceptually Defined?
Peripheral neuropathy refers to a condition characterized by damage or dysfunction of the peripheral nerves, which transmit signals between the central nervous system (the brain and spinal cord) and the rest of the body. This disorder can cause various symptoms, including numbness, tingling, weakness, and pain, typically in the hands and feet.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16507
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model